Upadacitinib (Rinvoq) gains psoriatic arthritis as second FDA-approved indicationDecember 15, 2021Rheumatology
Validity of commercial serologic tests for dermatomyositis still questionableNovember 24, 2021Rare DiseasesDermatologyRheumatology
Platelet-rich plasma injections show no benefit in knee OA in placebo-controlled trialNovember 23, 2021OsteoarthritisRheumatology
Long-term glucocorticoids in RA linked to increased cardiovascular riskNovember 17, 2021CardiologyRheumatology
Tofacitinib postmarketing trial data shed light on JAK inhibitor risksNovember 16, 2021CardiologyRheumatologyGastroenterology
mRNA COVID vaccine response found mostly robust in RA, SLE patientsNovember 11, 2021COVID-19 UpdatesVaccinesRheumatology
Drug combo at outset of polyarticular JIA benefits patients mostNovember 10, 2021PediatricsRare DiseasesMusculoskeletal DisordersRheumatology
Statins’ effects on CVD outweigh risk for diabetes in RANovember 9, 2021DiabetesRheumatologyCardiology
Lupus patients in remission see more flares with HCQ reduction, discontinuationNovember 9, 2021Rheumatology
Vitamin D and omega-3 supplements reduce autoimmune disease riskNovember 7, 2021RheumatologyPreventive CareMixed Topics
PT may lower risk of long-term opioid use after knee replacementNovember 1, 2021OsteoarthritisRheumatologyPain
Higher odds for preterm, C-section births seen in women with PsAOctober 28, 2021RheumatologyWomen's Health
